Source-Targeted Medicine: A Unified Bone Marrow Origin Hypothesis for Refractory Diseases - Redefining Systemic Lupus Erythematosus, Leukemia, and Cancer

IMPORTANT NOTICE: This paper is an outdated, deprecated draft and is formally superseded by the author.It is no longer considered the official or complete version of the hypothesis. The sole valid, final, and authoritative version is **Paper 18**:https://zenodo.org/records/19652558 All content, opinions, and conclusions in this outdated draft have been updated, corrected, and replaced by the final official version.This work is provided solely for historical version tracking purposes and is not intended for, and should not be used for, any medical, clinical, or treatment decision-making. This seminal work provides the final synthesis and a unified theoretical framework for the author’s series of seven research papers. It fundamentally challenges the traditional paradigms of modern immunology and oncology by introducing the Axiom of Immune Infallibility and the Local Bone Marrow Pathogenesis model. Key Contributions of this Final Synthesis: 1. Redefining SLE: Argues that Systemic Lupus Erythematosus is not a primary autoimmune malfunction but a necessary immune clearance response to defective platelets produced in specific bone marrow niches. 2. The "Fortress Flaw" in Cancer: Proposes that tumors are physical defense vulnerabilities (Inert Cell clusters) where opportunistic bacterial infections drive malignancy, rather than random genetic mutations. 3. The Logic of Source-Targeted Medicine: Shifts the therapeutic focus from systemic chemical suppression (chemotherapy/steroids) to localized physical intervention at the bone marrow source. 4. Validation of Immune Loyalty: Asserts that the human immune system is an evolutionarily perfected guardian that never attacks a healthy self, providing a philosophical and biological foundation for a 100% remission path. This paper integrates findings from the author's previous studies on platelet morphology, exercise duty loads, and cancer redefinition, offering a revolutionary roadmap for the cure of modern chronic malignancies.